Globe Token

Globe Token

ICO Ended
8,424 Views
The Globe Token (GLOB) is a cutting-edge cryptocurrency designed to bridge the gap between decentralized finance and everyday financial operations. Built on Base, a Layer 2 scaling solution for Ethereum, GLOB leverages blockchain technology to provide fast, secure, and cost-effective transactions. With a strong focus on transparency, innovation, and utility, GLOB aims to establish a robust ecosystem that addresses key challenges in the blockchain space while empowering users worldwide.
4.4
TOTAL SCORE
4.6
ICO PROFILE

(weight: 45%)

5
SOCIAL ACTIVITY

(weight: 35%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Bounty: Bounty
Pre-sale Time: 01 Jan 2025 - 28 Feb 2025
ICO Time: 01 Apr 2025 - 30 Apr 2025
Country: Worldwide
Restrictions: No
Token info
Ticker: GLOB
Platform: Ethereum
Available for sale: 40 GLOB (40%)
Total supply: 100,000,000 GLOB
Financial
Phase 1: Launch & Presale
Website and community launch<br /> Token presale and marketing campaigns<br /> DEX Listing<br /> Listing on Major Exchanges<br /> Partnerships
Phase 2: Ecosystem Development
Launch of staking platform<br /> Deployment of lending and borrowing protocol<br /> DAO governance model introduction<br /> Strategic partnerships<br /> Ambassadors Announcement
Phase 3: Expansion & Adoption
GLOB expansion of DeFi services<br /> Global community-building initiatives<br /> Continuous upgrades to the ecosystem<br /> Further development based on community proposals
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
Xsure
Xsure is a decentralized risk management platform that facilitates real-time communication between insurance providers and the end customer. With the help of machine learning and blockchain trust-less governance technologies we have managed to eliminate third parties from the whole insurance life-cycle and turn it into a dynamic process instead of a static one.
Active
Zwoop
Using AI and blockchain, Zwoop’s unique find engine helps shoppers find the products they want from any website, at the best available price with a single click checkout. Shoppers will be able to pay for products using cryptocurrency and ZWP tokens.
Upcoming
Squeezer
Squeezer is a platform that helps software developers build apps easily without tackling the entire blockchain infrastructure. It is also a powerful tool for providing high-quality blockchain software components to large enterprise organizations. Squeezer uses world-class microservices platforms, such as AWS Lambda, Google Functions, and Azure Functions.
Upcoming
Verifier
Verifier is an innovative technology designed to verify identity, events, deals, and any other kind of data. This is a blockchain based solution that verifies data quickly, accurately, trustworthy, and securely.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.